[HTML][HTML] Cannabinoid formulations and delivery systems: Current and future options to treat pain
B Stella, F Baratta, C Della Pepa, S Arpicco, D Gastaldi… - Drugs, 2021 - Springer
The field of Cannabis sativa L. research for medical purposes has been rapidly advancing in
recent decades and a growing body of evidence suggests that phytocannabinoids are …
recent decades and a growing body of evidence suggests that phytocannabinoids are …
[HTML][HTML] “Is medical cannabis safe for my patients?” A practical review of cannabis safety considerations
CA MacCallum, LA Lo, M Boivin - European Journal of Internal Medicine, 2021 - Elsevier
Medical cannabis use is increasing worldwide. Clinicians are commonly asked by patients
to provide guidance on its safety and efficacy. Although there has been an increase in …
to provide guidance on its safety and efficacy. Although there has been an increase in …
[HTML][HTML] Combined non-psychoactive Cannabis components cannabidiol and β-caryophyllene reduce chronic pain via CB1 interaction in a rat spinal cord injury model
A Eeswara, A Pacheco-Spiewak, S Jergova, J Sagen - PloS one, 2023 - journals.plos.org
The most frequently reported use of medical marijuana is for pain relief. However, its
psychoactive component Δ9-tetrahydrocannabinol (THC) causes significant side effects …
psychoactive component Δ9-tetrahydrocannabinol (THC) causes significant side effects …
The state-of-the-art pharmacotherapeutic options for the treatment of chronic non-cancer pain
RS D'Souza, B Langford, RE Wilson… - Expert Opinion on …, 2022 - Taylor & Francis
Introduction Pharmacotherapeutic options continue to expand for the treatment of chronic
non-cancer pain. There has been an increasing emphasis on multimodal analgesia. This …
non-cancer pain. There has been an increasing emphasis on multimodal analgesia. This …
[HTML][HTML] Practical strategies using medical cannabis to reduce harms associated with long term opioid use in chronic pain
Background: Chronic non-cancer pain (CNCP) is estimated to affect 20% of the adult
population. Current United States and Canadian Chronic non-cancer pain guidelines …
population. Current United States and Canadian Chronic non-cancer pain guidelines …
Changes in Prescribed Opioid Dosages Among Patients Receiving Medical Cannabis for Chronic Pain, New York State, 2017-2019
T Nguyen, Y Li, D Greene, S Stancliff… - JAMA Network …, 2023 - jamanetwork.com
Importance Patients with chronic pain often receive long-term opioid therapy (LOT), which
places them at risk of opioid use disorder and overdose. This presents the need for …
places them at risk of opioid use disorder and overdose. This presents the need for …
Inflammaging and cannabinoids
B Baban, H Khodadadi, ÉL Salles, V Costigliola… - Ageing research …, 2021 - Elsevier
Aging is a complex phenomenon associated with a wide spectrum of physical and
physiological changes affecting every part of all metazoans, if they escape death prior to …
physiological changes affecting every part of all metazoans, if they escape death prior to …
[HTML][HTML] A clinical framework for assessing cannabis-related impairment risk
CA MacCallum, LA Lo, CA Pistawka… - Frontiers in …, 2022 - frontiersin.org
Clinicians play an important role in promoting safe and responsible medical cannabis use.
One essential component to safe use is considering a patient's risk of neurocognitive …
One essential component to safe use is considering a patient's risk of neurocognitive …
[HTML][HTML] Online information on medical cannabis is not always aligned with scientific evidence and may raise unrealistic expectations
AC Macedo, AOV de Faria, I Bizzi, FA Moreira… - Journal of Cannabis …, 2022 - Springer
Background There is a growing literature on the potential medical uses of Cannabis sativa
and cannabinoid compounds. Although these have only been approved by regulatory …
and cannabinoid compounds. Although these have only been approved by regulatory …
[HTML][HTML] Cannabidiol signaling in the eye and its potential as an ocular therapeutic agent
A Aebersold, M Duff, L Sloan… - Cellular physiology and …, 2021 - ncbi.nlm.nih.gov
Cannabidiol (CBD), the major non-intoxicating constituent of Cannabis sativa, has gained
recent attention due to its putative therapeutic uses for a wide variety of diseases. CBD was …
recent attention due to its putative therapeutic uses for a wide variety of diseases. CBD was …